The clinical challenge presented by FOP is notably distinct from other disabling pathologies such as Duchenne Muscular Dystrophy (DMD), which is associated with loss of function mutations in the dystrophin gene DMD[53]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.